📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy
April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements from Co-Executive Directors Betty Aldworth and Ismail L. Ali, J.D., on today’s Executive Order regardin...
Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols
What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West and Fletcher Burdick argue that safety, lineage, context, and individualized care cannot be separate...
Evaluating the Pros and Cons of State Psychedelic Task Forces
While state legislatures across the U.S. are creating task forces to evaluate proposed legislation to regulate psychedelic-assisted therapies, there remains a disconnect between what advocates want and what legislato...
Scientists test if ketamine has antidepressant effects under anesthesia; France is the first to approve IV ketamine for severe suicidal crisis
Plus: New research on the role of trip sitters; Various state bills move to expand psychedelics research and access
The Life You Call “Normal” Was Designed
Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.
Wait, Are We In a Simulation?
This DMT laser experiment suggests yes, but neuroscientists say probably not. [...] Read More... The post Wait, Are We In a Simulation? appeared first on DoubleBlind Mag.
A Practitioner Statement on the Responsible Development of Ibogaine in the United States – Open Letter
Dear Colleagues,We write as a collective of practitioners, researchers, clinicians, and integration specialists with direct, long-term experience working with iboga and ibogaine across a range of settings. The growing...
Dr. Michael Alpert and Peter Alberding – ALS, Existential Distress, and Ketamine Therapy
Dr. Michael Alpert and Peter Alberding discuss ALS, ketamine-assisted psychotherapy, end-of-life fear, music, trust, and how one patient used ketamine to face mortality with more clarity and less fear. The post Dr. Mi...
Psychedelics in the Age of Eco-Anxiety
Eco-anxiety is a rising response to environmental crises that can be transformed into resilience and action through support, connection, and therapeutic psychedelic experiences. The post Psychedelics in the Age of Eco...
Where Does the World Go to Dance? Probs These EDM Festivals
A global guide to the festivals worth planning for. [...] Read More... The post Where Does the World Go to Dance? Probs These EDM Festivals appeared first on DoubleBlind Mag.
Inclius Alvarious’s Place Within Indigenous Society
A look at Sonoran Desert toad medicine through the lens of indigenous sovereignty, ecological strain, and the debate over synthetic versus naturally sourced 5-MeO-DMT. The post Inclius Alvarious’s Place Within Indigen...
Can you kill a bad trip?: 5 Questions for emergency physician Gregory Yates
Yates discusses experimental attempts to end a psychedelic trip early.
Psychedelic Faeries Take on Prohibition and Authoritarianism
Plus psychedelics and telepathy, ego death for the rich, and our brain on Chat GPT [...] Read More... The post Psychedelic Faeries Take on Prohibition and Authoritarianism appeared first on DoubleBlind Mag.
Introduction to Trip Sitting
The Art and Science of Holding Psychedelic Space
Heartbreak is a Bad Trip
Oli Genn-Bash describes how the aftermath of a sudden breakup felt like a prolonged ‘bad trip’, as well as the potential role of psychedelics in healing this emotional pain. The post Heartbreak is a Bad Trip appeared ...